Occipital Proton Magnetic Resonance Spectroscopy (1H-MRS) Reveals Normal Metabolite Concentrations in Retinal Visual Field Defects
暂无分享,去创建一个
Jeroen van der Grond | Frans W. Cornelissen | Christine C. Boucard | Johannes M. Hoogduin | F. Cornelissen | J. Hoogduin | J. van der Grond
[1] Marco A Zarbin,et al. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[2] H. Schild,et al. Proton magnetic resonance spectroscopy in Kennedy syndrome. , 1999, Archives of neurology.
[3] Matthijs Oudkerk,et al. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings , 2006, European Radiology.
[4] S. Resnikoff,et al. Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.
[5] A. Bird,et al. [Pathogenesis of lesions in late age-related macular disease]. , 2004, Journal francais d'ophtalmologie.
[6] Pradeep Rajagopalan,et al. Nuclear magnetic resonance spectroscopy: A review of neuropsychiatric applications , 1995, Progress in Neuro-psychopharmacology and Biological Psychiatry.
[7] P. Garnier,et al. N‐Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury , 2001, Journal of neurochemistry.
[8] B. Trapp,et al. N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.
[9] K. Ohtsuka,et al. N-Acetylaspartate Concentration in the Chiasm Measured by In Vivo Proton Magnetic Resonance Spectroscopy , 2004, Japanese Journal of Ophthalmology.
[10] Shrikanth S. Narayanan,et al. Imaging axonal damage in multiple sclerosis by means of MR spectroscopy , 2000, Neurological Sciences.
[11] N. Jansonius. Bayes’ theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] R. Weinreb,et al. Mechanisms of optic nerve damage in primary open angle glaucoma. , 1994, Survey of ophthalmology.
[13] R. Nickells,et al. Retinal Ganglion Cell Death in Glaucoma: The How, the Why, and the Maybe , 1996, Journal of glaucoma.
[14] M. Cynader,et al. Somatosensory cortical map changes following digit amputation in adult monkeys , 1984, The Journal of comparative neurology.
[15] S. Leung,et al. Proton magnetic resonance spectroscopy of late delayed radiation‐induced injury of the brain , 1999, Journal of magnetic resonance imaging : JMRI.
[16] R. Webster. Magnetic Resonance Spectroscopy , 1962, Nature.
[17] L W Jelinski,et al. Nuclear magnetic resonance spectroscopy. , 1995, Academic radiology.
[18] M. Hallett,et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. , 1997, Brain : a journal of neurology.
[19] R. Kuzniecky. Clinical applications of MR spectroscopy in epilepsy. , 2004, Neuroimaging clinics of North America.
[20] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[21] F Träber,et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. , 1998, Archives of neurology.
[22] P. Matthews,et al. Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.
[23] F. Träber,et al. In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration , 2002, Amino Acids.
[24] G. Fein,et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.
[25] B. Johansson,et al. Brain plasticity in health and disease. , 2004, The Keio journal of medicine.